Items

• Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways (2016-09)

  M. Ermisch, A. Bucsics, P. Vella Bonanno, F. Arickx, A. Bybau, T. Bochenek, M. van der Casteele, E. Digene, J. Furst, K. Garuoliene, M. van der Graff, J. Gulbinovic, A. Haycox, J. Jones, R. Joppi, O. Laius, I. Langner, A. Martin, V. Marković Peković, L. McCullagh, E. Magnusson, E. Nilsen, G. Selke, C. Sermet, S. Simoens, R. Sauremann, A. Schuurman, R. Ramos, V. Vlahović-Palčevski, C. Zara, B. Godman, Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways, Frontiers in Pharmacology, Vol. 7, pp. 1 - 9, Sep, 2016

• Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation (2017-08)

  P. Vella Bonanno, M. Ermisch, B. Godman, A. Martin, J. Van Den Bergh, L. Bezmelnitsyna, A. Bucsics, F. Arickx, A. Bybau, T. Bochenek, M. van der Casteele, E. Diogene, I. Eriksson, J. Furst, M. Gad, I. Greičiute-Kuprijanov, M. van der Graff, J. Gulbinovic, J. Jones, R. Joppi, M. Kalaba, O. Laius, I. Langner, I. Mardare, V. Marković Peković, E. Magnusson, O. Melien, D. Meshkov, G. Petrova, G. Selke, C. Sermet, S. Simoens, A. Schuurman, R. Ramos, J. Rodrigues, C. Zara, E. Zebedin-Brandl, A. Haycox, Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation, Frontiers in Pharmacology, Vol. 8, pp. 1 - 13, Aug, 2017

• Quality control of B-lines analysis in stress Echo 2020. (2018-09)

  M. Chiara Scali, Q. Ciampi, E. Picano, E. Bossone, F. Ferrara, R. Citro, P. Colonna, M. Costantino, L. Cortigiani, A. D'Andrea, S. Severino, C. Dodi, N. Gaibazzi, M. Galderisi, A. Barbieri, I. Monte, F. Mori, B. Reisenhofer, F. Re, F. Rigo, P. Trambaiolo, M. Amor, J. Lowenstein, P. Merlo, C. Borguezan Daros, J. de Castro E Silva Pretto, M. Miglioranza, M. A. R. Torres, C. de Azevedo Bellagamba, D. Chaves, I. Simova, A. Varga, J. Čelutkienė, J. Kasprzak, K. Wierzbowska-Drabik, P. Lipiec, P. Weiner-Mik, E. Szymczyk, K. Wdowiak-Okrojek, A. Djordjevic-Dikic, M. Dekleva, I. Stankovic, A. Neskovic, A. Zagatina, G. DI Salvo, J. Perez, A. Camarozano, A. Corciu, A. Boshchenko, F. Lattanzi, C. Cotrim, P. Fazendas, M. Haberka, B. Sobkowic, W. Kosmala, T. Witkowski, P. Gosciniak, A. Salustri, H. Rodrìguez-Zanella, L. Leal, A. Nikolic, S. Gligorova, M. Urluescu, M. Fiorino, G. Novo, T. Kovačević-Preradović, M. Ostojic, B. Beleslin, B. Villari, M. De Nes, M. Paterni, C. Carpeggiani, Quality control of B-lines analysis in stress Echo 2020., CARDIOVASCULAR ULTRASOUND, Sep, 2018

• Distribution maps of vegetation alliances in Europe (2022)

  Z. Preislerová, B. Jiménez-Alfaro, L. Mucina, C. Berg, G. Bonari, A. Kuzemko, F. Landucci, C. Marcenò, T. Monteiro-Henriques, P. Novák, D. Vynokurov, E. Bergmeier, J. Dengler, I. Apostolova, F. Bioret, I. Biurrun, J. Campos, J. Capelo, A. Čarni, S. Çoban, J. Csiky, M. Ćuk, R. Ćušterevska, F. Daniëls, M. De Sanctis, Y. Didukh, D. Dítě, G. Fanelli, Y. Golovanov, V. Golub, R. Guarino, M. Hájek, D. Iakushenko, A. Indreica, F. Jansen, A. Jašková, M. Jiroušek, V. Kalníková, A. Kavgacı, I. Kucherov, F. Küzmič, M. Lebedeva, J. Loidi, Z. Lososová, T. Lysenko, Đ. Milanović, V. Onyshchenko, G. Perrin, T. Peterka, V. Rašomavičius, M. Rodríguez-Rojo, J. Rodwell, S. Rūsiņa, D. Sánchez-Mata, J. Schaminée, Y. Semenishchenkov, N. Shevchenko, J. Šibík, Ž. Škvorc, V. Smagin, D. Stešević, V. Stupar, K. Šumberová, J. Theurillat, E. Tikhonova, R. Tzonev, M. Valachovič, K. Vassilev, W. Willner, S. Yamalov, M. Večeřa, M. Chytrý, Distribution maps of vegetation alliances in Europe, APPLIED VEGETATION SCIENCE: OFFICIAL ORGAN OF THE INTERNATIONAL ASSOCIATION FOR VEGETATION SCIENCE, Vol. 25, No. 1, pp. e12642 - e12642, 2022

• Dadaist elements in the works of Martin Margiela - Chapter in international scientific book (2013)

  J. Purgaj, S. Jevšnik, Dadaist elements in the works of Martin Margiela - Chapter in international scientific book, Trending now : new developments in fashion studies, pp. 125 - 132, Oxford: Inter-Disciplinary Press, Oxford, 2013

• Comparative analysis of morphometric parameters and conditions factors of grayling 3 + (Thymallus thymallus) from the Krušnica River and the Martin Brod fish farm (2021)

  S. Avdić, A. Bakrač, R. Dekić, I. Milunović, Comparative analysis of morphometric parameters and conditions factors of grayling 3 + (Thymallus thymallus) from the Krušnica River and the Martin Brod fish farm, International Journal of Fisheries and Aquatic Research, Vol. 6, No. 2, pp. 91 - 95, 2021

• Quality Management System – Way Ahead for the Food Industry (Upravljanje sistemom kvaliteta - korak naprijed za prehrambenu industriju) (2003)

  M. Sorak, O. Martin Belloso, A. Nikolić, S. Grujić, Quality Management System – Way Ahead for the Food Industry (Upravljanje sistemom kvaliteta - korak naprijed za prehrambenu industriju), University of Lleida (E), University of Banja Luka (BA), TEMPUS JEP Project 16140-2001, Banja Luka, 2003

• Effect of low and superatmosferic O2 modified atmosphere on the quality of fresh-cut pears. (2010-08)

  Z. Jandric, R. Soliva-Fortuny, G. Oms-Oliu, O. Martín-Belloso, S. Grujić, Effect of low and superatmosferic O2 modified atmosphere on the quality of fresh-cut pears., Applied Technologies and Innovations, Vol. 2, No. 2, pp. 29 - 39, Aug, 2010

• Essential to increase the use of generics in Europe to maintain comprehensive health care? (2012-01)

  B. Godman, M. Bennie, C. Baumgartel, L. Sović-Brkičić, T. Burkhardt, J. Furst, K. Garuoliene, M. Gomes, V. Marković Peković, A. Martin, C. Sermet, P. Skiold, M. van Woerkom, L. Vončina, L. Gustafsson, Essential to increase the use of generics in Europe to maintain comprehensive health care?, Farmeconomia. Health economics and therapeutic pathways, Vol. 13, No. 3S, pp. 5 - 20, Jan, 2012

• Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs (2013-05)

  R. Malmstrom, E. Digene, C. Baumgartel, M. Bennie, I. Bishop, A. Brzezinska, S. Campbell, A. Ferrario, A. Finlayson, J. Furst, K. Garuoliene, M. Gomes, I. Gutierrez-Ibarluzea, A. Haycox, K. Hviding, H. Herholz, M. Hoffman, S. Jan, J. Jones, R. Joppi, M. Kalaba, C. Kvalheim, O. Laius, I. Langner, J. Lonsdale, S. Loov, K. Malinowska, L. McCullagh, K. Paterson, V. Marković Peković, A. Martin, J. Piessnegger, G. Selke, C. Sermet, S. Simoens, C. Tulnay, D. Tomek, L. Vončina, V. Vlahović-Palčevski, J. Wale, M. Wilcock, M. Wladysiuk, M. van Woerkom, C. Zara, L. Gustafsson, Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs, Frontiers in Pharmacology, Vol. 4, pp. 1 - 31, May, 2013

• Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future (2015-05)

  B. Godman, M. Wilcock, A. Martin, S. Bryson, C. Baumgartel, T. Bochenek, W. de Bruyn, L. Sović-Brkičić, M. D'Agata, A. Fogele, A. Coma Fuste, J. Fraeyman, J. Furst, K. Garuoliene, H. Herholz, M. Hoffman, S. Jayathissa, H. Kwon, I. Langner, M. Kalaba, E. Magnusson, E. Anderse Karlssen, O. Laius, V. Marković Peković, E. Magnusson, S. McTaggart, H. Pedersen, J. Piessnegger, A. Ringerud, G. Selke, C. Sermet, K. Schiffers, P. Skiold, D. Tomek, A. Viksna, A. Vitry, C. Zara, R. Malmstrom, Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future, Generics and Biosimilars Initiative Journal, Vol. 4, No. 3, pp. 125 - 135, May, 2015

• Increasing understanding of alien species through citizen science (Alien-CSI) (2018-11)

  H. E. Roy, Q. Groom, T. Adriaens, G. Agnello, M. Antić, A. Archambeau, S. Bacher, A. Bonn, P. Brown, G. Brundu, B. Claramunt Lopez, M. Cleary, D. Cogalniceanu, M. de Groot, T. De Sousa, A. Deidun, F. Essl, Ž. Fišer Pečnikar, A. Gazda, E. Gervasini, M. M. Glavendekić, G. Gigot, S. D. Jelaska, J. M. Jeschke, D. Kaminski, P. K. Karachle, T. Komives, K. Lapin, F. Lucy, E. Marchante, D. Marisavljević, R. Marja, L. Martin Torrijos, A. Martinou, D. Matošević, C. Mifsud, J. Motiejunaite, H. Ojaveer, N. Pašalić, L. Pekarik, E. Per, J. Pergl, V. Pesic, M. Pocock, L. Reino, C. Ries, L. Rozylowicz, S. Schade, S. Sigurdsson, O. Steinitz, N. Stern, A. Teofilovski, J. Thorsson, R. Tomov, E. Tricarico, T. Trichova, K. Tsiamis, J. van Valkenburg, N. Vella, L. Verbrugge, G. Vetek, C. Villaverde, J. Witzell, A. Cardoso, Increasing understanding of alien species through citizen science (Alien-CSI), Research Ideas and Outcomes, No. 4, pp. 1 - 43, Nov, 2018

• Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets (2018-12)

  B. Godman, A. Bucsics, P. Vella Bonanno, W. Oortwijn, C. Rothe, A. Ferrario, S. Bosselli, A. Hill, A. Martin, S. Simoens, A. Kurdi, M. Gad, J. Gulbinovic, A. Timoney, T. Bochenek, A. Salem, I. Hoxha, R. Sauermann, A. Massele, A. Guerra Junior, G. Petrova, Z. Mitkova, G. Achniotou, O. Laius, C. Sermet, G. Selke, V. Kourafalos, J. Yfantopoulos, E. Magnusson, R. Joppi, M. Oluka, H. Kwon, A. Jakupi, F. Kalemeera, J. Fadare, O. Melien, M. Pomorski, M. Wladysiuk, V. Marković Peković, I. Mardare, D. Meshkov, T. Novakovic, J. Furst, D. Tomek, C. Zara, E. diogene, J. Meyer, R. Malmstrom, B. Wettermark, Z. Matsebula, S. Campbell, A. Haycox, Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets, Frontiers in public health, Vol. 6, No. Article 328, pp. 1 - 21, Dec, 2018

• Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA (2019-02)

  P. Vella Bonanno, A. Bucsics, S. Simoens, A. Martin, W. Oortwijn, J. Gulbinovic, C. Rothe, A. Timoney, A. Ferrario, M. Gad, A. Salem, I. Hoxha, R. Sauremann, M. Kamusheva, M. Dimitrova, G. Petrova, O. Laius, G. Selke, V. Kourafalos, J. Yfantopoulos, E. Magnusson, R. Joppi, A. Jakupi, T. Bochenek, M. Wladysiuk, C. Furtado, V. Marković Peković, I. Mardare, D. Meshkov, J. Furst, D. Tomek, M. Obach Cortadellas, C. Zara, A. Haycox, S. Campbell, B. Godman, Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA, Expert Review of Pharmacoeconomics & Outcome Research, Vol. 19, No. 3, pp. 251 - 261, Feb, 2019

• Ongoing Strategies to Improve the Management of Upper Respiratory Tract Infections and Reduce Inappropriate Antibiotic Use Particularly Among Lower and Middle-Income Countries: Findings and Implications for the Future (2020-02)

  B. Godman, M. Haque, J. McKimm, M. Abu Bakar, J. Sneddoh, J. Wale, S. Campbell, A. Martin, I. Hoxha, V. Abilova, B. Paramadhas, P. Mpinda-Joseph, M. Matome, L. Lovato, I. Sefah, A. Kurdi, S. Opanga, A. Jakupi, Z. Saleem, M. Hassali, D. Kibule, J. Fadare, T. Bochenek, C. Rothe, J. Fraeyman, V. Marković Peković, Lj. Bojanić, N. Schellack, J. Meyer, Z. Matsebula, T. Phuong, B. Thanh, S. Jan, A. Kalungia, S. Matpuri-Ziyowera, M. Sartelli, R. Hill, Ongoing Strategies to Improve the Management of Upper Respiratory Tract Infections and Reduce Inappropriate Antibiotic Use Particularly Among Lower and Middle-Income Countries: Findings and Implications for the Future, CURRENT MEDICAL RESEARCH AND OPINION, Vol. 36, No. 2, pp. 301 - 327, Feb, 2020

• Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries (2020-02)

  B. Godman, H. McCabe, T. Leong, D. Mueller, A. Martin, I. Hoxha, J. Mwita, G. Rwegerera, A. Massele, J. Costa, R. Nascimento, L. Lovato, K. Tachkov, P. Milushewa, O. Patrick, L. Niba, O. Laius, I. Sefah, S. Abdulsalim, F. Soleymani, L. Achieng, A. Guantai, M. Oluka, A. Jakupi, K. Logviss, M. Hassali, D. Kibule, F. Kalemeera, M. Mubita, I. Mardare, A. Alrasheedy, J. Furst, D. Tomek, V. Marković Peković, T. Phuong, B. Thanh, A. Kalungia, T. Zaranyika, N. Masuka, I. Olaru, J. Wale, R. Hill, A. Kurdi, A. Timoney, S. Campbell, J. Meyer, Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries, Expert Review of Pharmacoeconomics & Outcome Research, Vol. 20, No. 1, pp. 1 - 26, Feb, 2020

• Variation in the prices of oncology medicines across Europe and the implications for the future (2021-02)

  B. Godman, S. Simoens, A. Kurdi, G. Selke, J. Yfantopoulos, A. hill, J. Gulbinovic, A. Martin, A. Timoney, D. Gotham, J. Wale, T. Bochenek, I. Selke Krulichova, E. Allocati, I. Hoxha, A. Malaj, C. Hierlander, A. Nachtnebel, W. Hamelinck, Z. Mitkova, G. Petrova, O. Laius, C. Sermet, I. Langer, R. Joppi, A. Jakupi, E. Poplavski, I. Greičiute-Kuprijanov, P. Vella Bonanno, H. Piepenbrink, V. de Valk, R. Plisko, M. Wladysiuk, V. Marković Peković, I. Mardare, T. Novakovic, M. Parker, J. Furst, D. Tomek, K. Banasova, M. Obach Cortadellas, C. Zara, C. Pontes, M. Juhasz-Haverinen, P. Skiold, S. McTaggart, D. Wong-Rieger, S. Campbell, R. Hill, Variation in the prices of oncology medicines across Europe and the implications for the future, Generics and Biosimilars Initiative Journal, Vol. 10, No. 2, pp. 72 - 82, Feb, 2021

• Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021-03)

  B. Godman, A. Hill, S. Simoens, G. Selke, I. Selke Krulichova, C. Zampirolli, A. Martin, W. Oortwijn, A. Timoney, L. Gustafsson, L. Vončina, H. Kwon, J. Gulbinovic, D. Gotham, J. Wale, W. da Silva, T. Bochenek, A. Kurdi, E. Allocati, O. Ogunleye, J. Meyer, I. Hoxha, A. Malaj, C. Hierlander, R. Sauremann, W. Hamelinck, G. Petrova, O. Laius, I. Langner, J. Yfantopoulos, R. Joppi, A. Jakupi, I. Greičiute-Kuprijanov, P. Vella Bonanno, H. Piepenbrink, V. de Valk, M. Wladysiuk, V. Marković Peković, I. Mardare, J. Furst, D. Tomek, M. Obach Cortadellas, C. Zara, C. Pontes, S. McTaggart, T. Laba, O. Melien, D. Wong-Rieger, S. Bae, R. Hill, Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications, Expert Review of Pharmacoeconomics & Outcome Research, Vol. 21, No. 4, pp. 527 - 540, Mar, 2021

• Evidence-based public policy making for medicines across countries: findings and implications for the future (2021-08)

  B. Godman, J. Fadare, H. Kwon, C. Zampirolli, A. Kurdi, I. Piassi, D. Kibule, I. Hoxha, S. Opanga, Z. Saleem, T. Bochenek, V. Marković Peković, I. Mardare, A. Kalungia, S. Campbell, E. Allocati, A. Pisana, A. Martin, J. Meyer, Evidence-based public policy making for medicines across countries: findings and implications for the future, Journal of Comparative Effectiveness Research, Vol. 10, No. 12, pp. 1019 - 1052, Aug, 2021

• Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues (2022-03)

  B. Godman, B. Tubić, E. Allocati, M. Wladysiuk, S. McTaggart, A. Kurdi, M. Haque, S. McBride-Stewart, F. Kalemeera, A. Massele, I. Hoxha, V. Marković Peković, G. Petrova, K. Tachkov, O. Laius, A. Harsanyi, A. Inotai, A. Jakupi, S. Henkuzens, K. Garuoliene, P. Vella Bonanno, J. Rutkowski, I. Mardare, J. Furst, C. Pontes, C. Zara, M. Turu Pedrola, F. Akter, H. Kwon, A. Martin, R. Banzi, J. Wale, J. Gulbinovic, Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues, Journal of Applied Pharmaceutical Science, Vol. 12, No. 3, pp. 055 - 072, Mar, 2022